Paper 15 - PRIMARY ENDPOINT AND TRANSLATIONAL CORRELATES FROM EFTISARC-NEO: PHASE II TRIAL OF NEOADJUVANT EFTILAGIMOD ALPHA (EFTI), PEMBROLIZUMAB AND RADIOTHERAPY IN PATIENTS WITH RESECTABLE SOFT TISSUE SARCOMA

Author(s)

• 

  Pawel Sobczuk, MD PhD (he/him/his)

  Postdoctoral Fellow
  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland

  Slides

Co-Author(s)

• MW

  Michal Wagrodzki, MD, PhD

  Maria Sklodowska-Curie National Research Institute of Oncology,
  Warsaw, Mazowieckie, Poland
• PR

  Pawel Rogala, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• AW

  Aleksandra Wisniewska, MSc

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• AM

  Ann Mariuk-Jarema, MD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• 

  Paulina Jagodzinska-Mucha, MD PhD

  doctor
  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• TS

  Tomasz Switaj, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• PT

  Pawel Teterycz, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• 

  Aneta W. Borkowska, PhD

  MD
  Maria Sklodowska-Curie National Research Institute of Oncology
  Warszawa, Mazowieckie, Poland
• KZ

  Konrad Zaborowski, MD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• MZ

  Marcin Zdzienicki, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• 

  Joanna M. Placzke, MD (she/her/hers)

  medical oncologist
  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• AS

  Anna Szumera-Cieckiewicz, MD, PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• PC

  Patrycja Castaneda-Wysocka, MD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• NR

  Natalia Rusetska, PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• ES

  Elzbieta Sarnowska, PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• 

  Piotr Rutkowski, MD, PhD

  Head of Department of Soft Tissue/Bone Sarcoma and Melanoma
  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• KK

  Katarzyna Kozak, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland